BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 14603552)

  • 21. [Essential thrombocythemia: conventional therapy].
    Grossi A; Vannucchi AM; Longo G; Rafanelli D; Rossi Ferrini P
    Haematologica; 1991 Jun; 76 Suppl 3():368-70. PubMed ID: 1752534
    [No Abstract]   [Full Text] [Related]  

  • 22. [Polycythaemia vera--diagnosis and therapy].
    Lechner K; Geissler K; Gisslinger H
    Wien Klin Wochenschr; 1999 Aug; 111(15):582-9. PubMed ID: 10483672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polycythemia vera in a patient with the human immunodeficiency virus: a case report.
    Sassaki MG; Souza CA; Siciliano RF; Leite AG; Padilha SL
    Braz J Infect Dis; 2000 Aug; 4(4):204-7. PubMed ID: 11184768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
    Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
    N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment related changes in antifibrinolytic activity in patients with polycythemia vera.
    Sonmez M; Saglam F; Karahan SC; Erkut N; Mentese A; Sonmez B; Ucar F; Topbas M; Ovali E
    Hematology; 2010 Dec; 15(6):391-6. PubMed ID: 21114901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polycythemia vera and pregnancy: difficulties for diagnosis and treatment].
    Deruelle P; Bouhassoun J; Trillot N; Jude B; Ducloy AS; Subtil D
    Gynecol Obstet Fertil; 2005 May; 33(5):331-7. PubMed ID: 15878688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of polycythemia vera.
    Silver RT
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):437-42. PubMed ID: 16810620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk-adapted therapy in essential thrombocythemia and polycythemia vera.
    Finazzi G; Barbui T
    Blood Rev; 2005 Sep; 19(5):243-52. PubMed ID: 15963833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycythemia vera: diagnosis and treatment 2002.
    Berlin NI
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):330-6. PubMed ID: 12113056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.
    Andréasson B; Carneskog J; Lindstedt G; Lundberg PA; Swolin B; Wadenvik H; Kutti J
    Leuk Lymphoma; 2000 Mar; 37(1-2):189-95. PubMed ID: 10721786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
    J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based management of polycythemia vera.
    Barbui T; Finazzi G
    Best Pract Res Clin Haematol; 2006; 19(3):483-93. PubMed ID: 16781485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Polycythemia vera. Clinical course, diagnosis and therapy].
    Braumann D; Mainzer K
    Dtsch Med Wochenschr; 1983 Oct; 108(40):1524-9. PubMed ID: 6617509
    [No Abstract]   [Full Text] [Related]  

  • 34. Polycythemia vera: a retrospective and reprise.
    Berlin NI; Wasserman LR
    J Lab Clin Med; 1997 Oct; 130(4):365-73. PubMed ID: 9358074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history and management of polycythemia vera.
    Hoffman R; Wasserman LR
    Adv Intern Med; 1979; 24():255-85. PubMed ID: 371361
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of patients with polycythaemia vera: results of a survey among Swedish haematologists.
    Andreasson B; Löfvenberg E; Westin J
    Eur J Haematol; 2005 Jun; 74(6):489-95. PubMed ID: 15876252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expertise-based management in essential thrombocythemia and polycythemia vera.
    Finazzi G; Barbui T
    Cancer J; 2007; 13(6):372-6. PubMed ID: 18032974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia.
    Elliott MA; Tefferi A
    Br J Haematol; 2005 Feb; 128(3):275-90. PubMed ID: 15667529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycythemia vera, the hematocrit, and blood-volume physiology.
    Spivak JL
    N Engl J Med; 2013 Jan; 368(1):76-8. PubMed ID: 23216617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.